Quinine sulfate dihydrate
Common Name: | Quinine sulfate dihydrate |
IUPAC Name: | (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;sulfuric acid;dihydrate |
Molecular Formula: | C40H58N4O12S |
SMILES: | COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.O.O.OS(=O)(=O)O |
Inchi: | 1S/2C20H24N2O2.H2O4S.2H2O/c2*1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;1-5(2,3)4;;/h2*3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3;(H2,1,2,3,4);2*1H2/t2*13-,14-,19-,20+;;;/m00.../s1 |
Inchi Key: | ZHNFLHYOFXQIOW-LPYZJUEESA-N |
Cas No: | 6119-70-6 |
Name | Value |
Lipinski Violations | 3 |
Ghose Violations | 3 |
Veber Violations | 1 |
Egan Violations | 1 |
Muegge Violations | 5 |
---|
Name | Value |
Molecular Weight (g/mol) | 782.94 |
Mass (g/mol) | 782.356 |
Molar Refractivity | 219.79 |
Net Charge | |
HBD | 6 |
HBA | 14 |
Rt Bonds | 8 |
Rings | |
TPSA | 192.62 |
Hetero Atoms | |
Heavy Atoms | 55 |
Aromatic Heavy Atoms | 20 |
Melting Point (°C) | 224.00 to 225.00 |
Boiling Point (°C@760.00mm Hg) | 495.90 |
Vapor Pressure (mmHg@25.00 °C) | 0 |
Vapor Density (Air =1) | |
Fraction Csp3 | 0.45 |
LogP | |
iLOGP | 4.69 |
XLOGP3 | 1.10 |
WLOGP | 5.24 |
MLOGP | 0.27 |
ESOL Log S | -5.13 |
ESOL Solubility (mg/ml) | 0.006 |
ESOL Solubility (mol/l) | 0 |
ESOL Class: esol_class | Moderately soluble |
Ali Log S | -4.74 |
Ali Solubility (mg/ml) | 0.01 |
Ali Solubility (mol/l) | 0 |
Ali Class | Moderately soluble |
Silicos-IT LogSw | -4.31 |
Silicos-IT Solubility (mg/ml) | 0.04 |
Silicos-IT Solubility (mol/l) | 0 |
Silicos-IT Class | Moderately soluble |
---|
Name | Value |
GI Absorption | Low |
BBB Permeable | 0 |
PgP Substrate | 1 |
Log Kp (cm/s) | -10.29 |
Bioavailability Score | 0.17 |
Caco2 | 0 |
Human Intestinal Absorption | 1 |
Plasm Protein Binding | 0.744 |
CYP1A2 Inhibitor | 0 |
CYP2C19 Inhibitor | 0 |
CYP2C9 Inhibitor | 0 |
CYP2D6 inhibitor | 0 |
CYP3A4 inhibitor | 0 |
Ames mutagenesis | 0 |
Acute Oral Toxicity | 4.228 |
Carcinogenicity (Binary) | 0 |
Carcinogenicity (Trinary) | Non-required |
Eye Irritation | 0 |
Hepatotoxicity | 0 |
Androgen Receptor Binding | 1 |
Aromatase Binding | 1 |
Estrogen Receptor Binding | 1 |
Glucocorticoid Receptor Binding | 1 |
Thyroid Receptor Binding | 1 |
BRCP inhibitor | 0 |
BSEP inhibitor | 1 |
OATP1B1 inhibitor | 1 |
OATP1B3 inhibitor | 1 |
OATP2B1 inhibitor | 0 |
OCT1 inhibitor | 0 |
OCT2 inhibitor | 0 |
---|